#VisualAbstract: Atezolizumab may increase overall survival in patients with metastatic non-small-cell lung cancer
1. Atezolizumab significantly increased overall survival compared to platinum-based combination chemotherapy in participants with untreated metastatic non-small-cell lung cancer (NSCLC) ...